findmyKOL
Clinical trialNCT04305613Active, not recruitingObservational

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

SponsorAbramson Cancer Center at Penn MedicineEnrollment221CardiotoxicityLung Cancer Stage IILung Cancer Stage IIIRadiation Toxicity
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama

    Birmingham, Alabama, United States

  • the Brigham and Women'S Hospital

    Boston, Massachusetts, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Rutger'S University / Cancer Institute of New Jersey

    New Brunswick, New Jersey, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Lancaster General Hospital

    Lancaster, Pennsylvania, United States

  • Abramson Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Chester County Hospital

    West Chester, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Sept 2020
Primary completion
30 Sept 2026
Completion
31 Dec 2030
Last update posted
2 Oct 2025
Registered enrollment
221
Registry id
NCT04305613

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.